Across the pharma value chain, increasing complexity is creating many opportunities for companies to provide value-added services to key constituents. This is driving strong investor interest throughout the landscape. “We’re seeing a convergence of pharmacy and pharma services as providers seek ways to strengthen their relationships with patients, providers, payers, and pharma by solving more challenges for their clients,” says Cheairs Porter, a managing director in Harris Williams’ Healthcare & Life Sciences Group. “Models like hub services illustrate this theme in action.” Here, Harris Williams shares why hub services are capturing investor attention and how its recent clients, Mercalis and AnovoRx, demonstrate the opportunity.
Read the full article: The Convergence of Pharmacy and Pharma Services: Hub Services Show Opportunity //
Source: https://www.harriswilliams.com/our-insights/hcls-convergence-pharmacy-pharmacy-services-hub-services-m&a-trends